Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Walsh TR - Carbapenem resistance continues to increase both in number and into new species/strain types, but the therapeutic options remain woefully inadequate - a dilemma that will not improve in the foreseeable future.

Related Articles

Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre
Journal of Medical Microbiology, 10/22/09    Relevance Score: 84%

Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae
Infection Control and Hospital Epidemiology, 10/28/09    Relevance Score: 80%

Novel Genetic Environment of the Carbapenem-Hydrolyzing beta-Lactamase KPC-2 among Enterobacteriaceae in China
Antimicrobial Agents and Chemotherapy, 10/06/09    Relevance Score: 80%

Today in Antimicrobials...keeping you current

Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study
Diagnostic Microbiology and Infectious Disease, 12/09/09

Screening of some Tanzanian medicinal plants for their trypanocidal and cytotoxic activities
Phytotherapy Research, 12/09/09

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
The Lancet - Early Online Publication, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address